Join today to start taking advantage of all the benefits offered by NJSHP!
During this time communication is critical. NJSHP would like to support the health-system members and residents of New Jersey.
Please send any suggested content to Stella Williams (firstname.lastname@example.org) so we can review and share them as appropriate.
Thursday, March 19, 2020
Information from the NJ Board of Pharmacy:
- Guidance for the pharmacy community relating to COVID-19
Information from the Department of Health:
- DOH spotlight and recent news
- DOH information for healthcare professionals on COVID-19
Click here to view the provided resources
Useful links on COVID-19 resources
John Hopkins University
Current UW Medicine protocols:
Penn Medicine's treatment guidelines
Michigan Medicine treatment guidelines
Drug and Prescription Updates
Recent publications on medication management with COVID-19
Drug diversion by the DEA
ACE Inhibitors and ARBs use
Darunavir treatment lacking evidence
In light of the rapidly evolving COVID-19 pandemic, the demand for garbing and personal protective equipment (PPE) and alcohol-based hand sanitizer is expected to outpace available supply. During this pandemic, USP supports State Boards and other regulators using risk-based enforcement discretion related to the implementation of USP compounding standards and the compounding of alcohol-based sanitizers for consumer use.
The USP Compounding Expert Committee developed the following information resources that may be of assistance during this public health emergency:
- Compounding Alcohol-Based Hand Sanitizer During the COVID-19 Pandemic
- USP Response to Shortages of Garb and PPE for Sterile Compounding During the COVID-19 Pandemic
Any additional questions should be directed to the USP Healthcare Quality and Safety staff at email@example.com